The Use of Rifaximin in Patients With Cirrhosis

Rifaximin is an oral nonsystemic antibiotic with minimal gastrointestinal absorption and broad‐spectrum antibacterial activity covering both gram‐positive and gram‐negative organisms. Rifaximin is currently used worldwide in patients with cirrhosis for preventing recurrent HE because its efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Caraceni, Paolo, Vargas, Victor, Solà, Elsa, Alessandria, Carlo, de Wit, Koos, Trebicka, Jonel, Angeli, Paolo, Mookerjee, Rajeshwar P., Durand, François, Pose, Elisa, Krag, Aleksander, Bajaj, Jasmohan S., Beuers, Ulrich, Ginès, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518409/
https://www.ncbi.nlm.nih.gov/pubmed/33421158
http://dx.doi.org/10.1002/hep.31708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518409/
https://www.ncbi.nlm.nih.gov/pubmed/33421158
http://dx.doi.org/10.1002/hep.31708

Ejemplares similares